US-based mutual insurance company Sham has helped Alizé Pharma, a France-based metabolic diseases and cancer group, raise €3.3m ($4.1m).
The round was joined by Octalfa, a family office, Cema Inc, a Canada-based holding company, and Thierry Abribat, Alizé’s founder and president. In 2009 Sham, Octalfa and Cema invested in a €3m round, taking the amount raised by Alizé since its founding in 2007 to €4.8m.
Alizé Pharma owns five families of patents, with a total of 34 patents and patent…
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
